Natriuretic peptides (NPs) are released from the heart in response to pressure and volume
overload. B-type natriuretic peptide (BNP) and N-terminal-proBNP have become important …

Biochemical marker testing has revolutionized the approach to diagnosis and management
of heart failure over the past decade. There is an unsurpassed excitement in the heart failure …

Background: Both BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro B-type
natriuretic peptide) are widely used to aid diagnosis, assess the effect of therapy, and predict …

The utility of aminoterminal pro-brain natriuretic peptide (NT-proBNP) testing in the
emergency department to rule out acute congestive heart failure (CHF) and the optimal …

We assessed cardiovascular disease (CVD) incidence in 1474 survivors of Hodgkin
lymphoma (HL) younger than 41 years at treatment (1965-1995). Multivariable Cox …

Background: The B-type or brain natriuretic peptides (BNP) and the amino-terminal probrain
natriuretic peptide (NT-proBNP) are good markers of prognosis and diagnosis in chronic …

Aims B-type natriuretic peptide (BNP) and C-reactive protein (CRP) predict atrial fibrillation
(AF) risk. However, their risk stratification abilities in the broad community remain uncertain …

Objectives: This study investigated relationships between plasma myeloperoxidase (MPO),
protein oxidation markers, and clinical outcome retrospectively in patients after acute …

Objectives: This study was designed to investigate whether the addition of N-terminal pro–B-
type natriuretic peptide–guided, intensive patient management (BM) to multidisciplinary care …

Objectives: The purpose of this study was to assess the association between B-type
natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and the …